Scientists hail promise of first effective Ebola treatments in Congo trial

A health worker fills a syringe with Ebola vaccine before injecting it to a patient, in Goma, Democratic Republic of Congo, August 5, 2019. [Reuters]

Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed survival rate of as much as 90% in a clinical trial in Congo.

Two experimental drugs - Regeneron’s REGN-EB3 and a monoclonal antibody called mAb114 - were both developed using antibodies harvested from survivors of Ebola infection.